Global Muscle Relaxers Market Research Report 2023
Muscle relaxers are a group of drugs that have a sedative effect and may be prescribed for back, neck, and other musculoskeletal pain.
According to QYResearch’s new survey, global Muscle Relaxers market is projected to reach US$ 5065.3 million in 2029, increasing from US$ 3740 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Muscle Relaxers market research.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth. For instance, 1 in 6 people worldwide will be 60 or older by 2030. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Muscle Relaxers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
According to QYResearch’s new survey, global Muscle Relaxers market is projected to reach US$ 5065.3 million in 2029, increasing from US$ 3740 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Muscle Relaxers market research.
According to a study of Global Burden of Disease (GBD) 2021 data, 1.71 billion individuals globally suffer from musculoskeletal diseases, such as osteoarthritis, rheumatoid arthritis, neck discomfort, low back pain, fractures, and other injuries. People of all ages are afflicted by musculoskeletal problems; however, the prevalence varies by age and diagnosis. With over 149 million years lived with disability (YLDs), or 17% of all YLDs worldwide, musculoskeletal diseases are the main cause of YLDs. The need for muscle relaxants drugs is also being driven by the growing geriatric population, as this group is more vulnerable to illnesses including back pain, muscular tightness, and muscle spasms, especially those connected to injuries to the spine. As a result of this disease muscle relaxants are more in demand, which further drives market growth. For instance, 1 in 6 people worldwide will be 60 or older by 2030. The number of individuals in the world who are 60 or older will double (to 2.1 billion) by 2050. Between 2020 and 2050, the number of people 80 or older is projected to triple, reaching 426 million.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Muscle Relaxers market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Pfizer
- Allergan
- Ipsen Group
- Teva Pharmaceuticals
- Novartis
- Johnson & Johnson
- Takeda Pharmaceutical
- Sun Pharmaceutical
- Merz Pharma
- Mylan
- Fresenius Kabi
- Endo International
- Par Sterile Products
- Acorda Therapeutics
- SteriMax Inc
- Emcure Pharmaceuticals
- Upsher-Smith Laboratories
- Orient Pharma
- Daewoong Pharmaceutical
- Methocarbamol
- Cyclobenzaprine
- Tizanidine
- Baclofen
- Others
- Online Pharmacies
- Retail Pharmacies
- Hospital Pharmacies
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscle Relaxers Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Methocarbamol
1.2.3 Cyclobenzaprine
1.2.4 Tizanidine
1.2.5 Baclofen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Muscle Relaxers Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Muscle Relaxers Market Perspective (2018-2029)
2.2 Muscle Relaxers Growth Trends by Region
2.2.1 Global Muscle Relaxers Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Muscle Relaxers Historic Market Size by Region (2018-2023)
2.2.3 Muscle Relaxers Forecasted Market Size by Region (2024-2029)
2.3 Muscle Relaxers Market Dynamics
2.3.1 Muscle Relaxers Industry Trends
2.3.2 Muscle Relaxers Market Drivers
2.3.3 Muscle Relaxers Market Challenges
2.3.4 Muscle Relaxers Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Muscle Relaxers Players by Revenue
3.1.1 Global Top Muscle Relaxers Players by Revenue (2018-2023)
3.1.2 Global Muscle Relaxers Revenue Market Share by Players (2018-2023)
3.2 Global Muscle Relaxers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Muscle Relaxers Revenue
3.4 Global Muscle Relaxers Market Concentration Ratio
3.4.1 Global Muscle Relaxers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscle Relaxers Revenue in 2022
3.5 Muscle Relaxers Key Players Head office and Area Served
3.6 Key Players Muscle Relaxers Product Solution and Service
3.7 Date of Enter into Muscle Relaxers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MUSCLE RELAXERS BREAKDOWN DATA BY TYPE
4.1 Global Muscle Relaxers Historic Market Size by Type (2018-2023)
4.2 Global Muscle Relaxers Forecasted Market Size by Type (2024-2029)
5 MUSCLE RELAXERS BREAKDOWN DATA BY APPLICATION
5.1 Global Muscle Relaxers Historic Market Size by Application (2018-2023)
5.2 Global Muscle Relaxers Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Muscle Relaxers Market Size (2018-2029)
6.2 North America Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Muscle Relaxers Market Size by Country (2018-2023)
6.4 North America Muscle Relaxers Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Muscle Relaxers Market Size (2018-2029)
7.2 Europe Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Muscle Relaxers Market Size by Country (2018-2023)
7.4 Europe Muscle Relaxers Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Muscle Relaxers Market Size (2018-2029)
8.2 Asia-Pacific Muscle Relaxers Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Muscle Relaxers Market Size by Region (2018-2023)
8.4 Asia-Pacific Muscle Relaxers Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Muscle Relaxers Market Size (2018-2029)
9.2 Latin America Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Muscle Relaxers Market Size by Country (2018-2023)
9.4 Latin America Muscle Relaxers Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Muscle Relaxers Market Size (2018-2029)
10.2 Middle East & Africa Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Muscle Relaxers Market Size by Country (2018-2023)
10.4 Middle East & Africa Muscle Relaxers Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Muscle Relaxers Introduction
11.1.4 Pfizer Revenue in Muscle Relaxers Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Muscle Relaxers Introduction
11.2.4 Allergan Revenue in Muscle Relaxers Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Ipsen Group
11.3.1 Ipsen Group Company Detail
11.3.2 Ipsen Group Business Overview
11.3.3 Ipsen Group Muscle Relaxers Introduction
11.3.4 Ipsen Group Revenue in Muscle Relaxers Business (2018-2023)
11.3.5 Ipsen Group Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Detail
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Muscle Relaxers Introduction
11.4.4 Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Muscle Relaxers Introduction
11.5.4 Novartis Revenue in Muscle Relaxers Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Muscle Relaxers Introduction
11.6.4 Johnson & Johnson Revenue in Muscle Relaxers Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Muscle Relaxers Introduction
11.7.4 Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Detail
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Muscle Relaxers Introduction
11.8.4 Sun Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Merz Pharma
11.9.1 Merz Pharma Company Detail
11.9.2 Merz Pharma Business Overview
11.9.3 Merz Pharma Muscle Relaxers Introduction
11.9.4 Merz Pharma Revenue in Muscle Relaxers Business (2018-2023)
11.9.5 Merz Pharma Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Muscle Relaxers Introduction
11.10.4 Mylan Revenue in Muscle Relaxers Business (2018-2023)
11.10.5 Mylan Recent Development
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Detail
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Muscle Relaxers Introduction
11.11.4 Fresenius Kabi Revenue in Muscle Relaxers Business (2018-2023)
11.11.5 Fresenius Kabi Recent Development
11.12 Endo International
11.12.1 Endo International Company Detail
11.12.2 Endo International Business Overview
11.12.3 Endo International Muscle Relaxers Introduction
11.12.4 Endo International Revenue in Muscle Relaxers Business (2018-2023)
11.12.5 Endo International Recent Development
11.13 Par Sterile Products
11.13.1 Par Sterile Products Company Detail
11.13.2 Par Sterile Products Business Overview
11.13.3 Par Sterile Products Muscle Relaxers Introduction
11.13.4 Par Sterile Products Revenue in Muscle Relaxers Business (2018-2023)
11.13.5 Par Sterile Products Recent Development
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Company Detail
11.14.2 Acorda Therapeutics Business Overview
11.14.3 Acorda Therapeutics Muscle Relaxers Introduction
11.14.4 Acorda Therapeutics Revenue in Muscle Relaxers Business (2018-2023)
11.14.5 Acorda Therapeutics Recent Development
11.15 SteriMax Inc
11.15.1 SteriMax Inc Company Detail
11.15.2 SteriMax Inc Business Overview
11.15.3 SteriMax Inc Muscle Relaxers Introduction
11.15.4 SteriMax Inc Revenue in Muscle Relaxers Business (2018-2023)
11.15.5 SteriMax Inc Recent Development
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Company Detail
11.16.2 Emcure Pharmaceuticals Business Overview
11.16.3 Emcure Pharmaceuticals Muscle Relaxers Introduction
11.16.4 Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023)
11.16.5 Emcure Pharmaceuticals Recent Development
11.17 Upsher-Smith Laboratories
11.17.1 Upsher-Smith Laboratories Company Detail
11.17.2 Upsher-Smith Laboratories Business Overview
11.17.3 Upsher-Smith Laboratories Muscle Relaxers Introduction
11.17.4 Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2018-2023)
11.17.5 Upsher-Smith Laboratories Recent Development
11.18 Orient Pharma
11.18.1 Orient Pharma Company Detail
11.18.2 Orient Pharma Business Overview
11.18.3 Orient Pharma Muscle Relaxers Introduction
11.18.4 Orient Pharma Revenue in Muscle Relaxers Business (2018-2023)
11.18.5 Orient Pharma Recent Development
11.19 Daewoong Pharmaceutical
11.19.1 Daewoong Pharmaceutical Company Detail
11.19.2 Daewoong Pharmaceutical Business Overview
11.19.3 Daewoong Pharmaceutical Muscle Relaxers Introduction
11.19.4 Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.19.5 Daewoong Pharmaceutical Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscle Relaxers Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Methocarbamol
1.2.3 Cyclobenzaprine
1.2.4 Tizanidine
1.2.5 Baclofen
1.2.6 Others
1.3 Market by Application
1.3.1 Global Muscle Relaxers Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Muscle Relaxers Market Perspective (2018-2029)
2.2 Muscle Relaxers Growth Trends by Region
2.2.1 Global Muscle Relaxers Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Muscle Relaxers Historic Market Size by Region (2018-2023)
2.2.3 Muscle Relaxers Forecasted Market Size by Region (2024-2029)
2.3 Muscle Relaxers Market Dynamics
2.3.1 Muscle Relaxers Industry Trends
2.3.2 Muscle Relaxers Market Drivers
2.3.3 Muscle Relaxers Market Challenges
2.3.4 Muscle Relaxers Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Muscle Relaxers Players by Revenue
3.1.1 Global Top Muscle Relaxers Players by Revenue (2018-2023)
3.1.2 Global Muscle Relaxers Revenue Market Share by Players (2018-2023)
3.2 Global Muscle Relaxers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Muscle Relaxers Revenue
3.4 Global Muscle Relaxers Market Concentration Ratio
3.4.1 Global Muscle Relaxers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscle Relaxers Revenue in 2022
3.5 Muscle Relaxers Key Players Head office and Area Served
3.6 Key Players Muscle Relaxers Product Solution and Service
3.7 Date of Enter into Muscle Relaxers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MUSCLE RELAXERS BREAKDOWN DATA BY TYPE
4.1 Global Muscle Relaxers Historic Market Size by Type (2018-2023)
4.2 Global Muscle Relaxers Forecasted Market Size by Type (2024-2029)
5 MUSCLE RELAXERS BREAKDOWN DATA BY APPLICATION
5.1 Global Muscle Relaxers Historic Market Size by Application (2018-2023)
5.2 Global Muscle Relaxers Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Muscle Relaxers Market Size (2018-2029)
6.2 North America Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Muscle Relaxers Market Size by Country (2018-2023)
6.4 North America Muscle Relaxers Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe Muscle Relaxers Market Size (2018-2029)
7.2 Europe Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Muscle Relaxers Market Size by Country (2018-2023)
7.4 Europe Muscle Relaxers Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific Muscle Relaxers Market Size (2018-2029)
8.2 Asia-Pacific Muscle Relaxers Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Muscle Relaxers Market Size by Region (2018-2023)
8.4 Asia-Pacific Muscle Relaxers Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America Muscle Relaxers Market Size (2018-2029)
9.2 Latin America Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Muscle Relaxers Market Size by Country (2018-2023)
9.4 Latin America Muscle Relaxers Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Muscle Relaxers Market Size (2018-2029)
10.2 Middle East & Africa Muscle Relaxers Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Muscle Relaxers Market Size by Country (2018-2023)
10.4 Middle East & Africa Muscle Relaxers Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Muscle Relaxers Introduction
11.1.4 Pfizer Revenue in Muscle Relaxers Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Allergan
11.2.1 Allergan Company Detail
11.2.2 Allergan Business Overview
11.2.3 Allergan Muscle Relaxers Introduction
11.2.4 Allergan Revenue in Muscle Relaxers Business (2018-2023)
11.2.5 Allergan Recent Development
11.3 Ipsen Group
11.3.1 Ipsen Group Company Detail
11.3.2 Ipsen Group Business Overview
11.3.3 Ipsen Group Muscle Relaxers Introduction
11.3.4 Ipsen Group Revenue in Muscle Relaxers Business (2018-2023)
11.3.5 Ipsen Group Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Detail
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Muscle Relaxers Introduction
11.4.4 Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Muscle Relaxers Introduction
11.5.4 Novartis Revenue in Muscle Relaxers Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Muscle Relaxers Introduction
11.6.4 Johnson & Johnson Revenue in Muscle Relaxers Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Muscle Relaxers Introduction
11.7.4 Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Detail
11.8.2 Sun Pharmaceutical Business Overview
11.8.3 Sun Pharmaceutical Muscle Relaxers Introduction
11.8.4 Sun Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.8.5 Sun Pharmaceutical Recent Development
11.9 Merz Pharma
11.9.1 Merz Pharma Company Detail
11.9.2 Merz Pharma Business Overview
11.9.3 Merz Pharma Muscle Relaxers Introduction
11.9.4 Merz Pharma Revenue in Muscle Relaxers Business (2018-2023)
11.9.5 Merz Pharma Recent Development
11.10 Mylan
11.10.1 Mylan Company Detail
11.10.2 Mylan Business Overview
11.10.3 Mylan Muscle Relaxers Introduction
11.10.4 Mylan Revenue in Muscle Relaxers Business (2018-2023)
11.10.5 Mylan Recent Development
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Detail
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Muscle Relaxers Introduction
11.11.4 Fresenius Kabi Revenue in Muscle Relaxers Business (2018-2023)
11.11.5 Fresenius Kabi Recent Development
11.12 Endo International
11.12.1 Endo International Company Detail
11.12.2 Endo International Business Overview
11.12.3 Endo International Muscle Relaxers Introduction
11.12.4 Endo International Revenue in Muscle Relaxers Business (2018-2023)
11.12.5 Endo International Recent Development
11.13 Par Sterile Products
11.13.1 Par Sterile Products Company Detail
11.13.2 Par Sterile Products Business Overview
11.13.3 Par Sterile Products Muscle Relaxers Introduction
11.13.4 Par Sterile Products Revenue in Muscle Relaxers Business (2018-2023)
11.13.5 Par Sterile Products Recent Development
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Company Detail
11.14.2 Acorda Therapeutics Business Overview
11.14.3 Acorda Therapeutics Muscle Relaxers Introduction
11.14.4 Acorda Therapeutics Revenue in Muscle Relaxers Business (2018-2023)
11.14.5 Acorda Therapeutics Recent Development
11.15 SteriMax Inc
11.15.1 SteriMax Inc Company Detail
11.15.2 SteriMax Inc Business Overview
11.15.3 SteriMax Inc Muscle Relaxers Introduction
11.15.4 SteriMax Inc Revenue in Muscle Relaxers Business (2018-2023)
11.15.5 SteriMax Inc Recent Development
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Company Detail
11.16.2 Emcure Pharmaceuticals Business Overview
11.16.3 Emcure Pharmaceuticals Muscle Relaxers Introduction
11.16.4 Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023)
11.16.5 Emcure Pharmaceuticals Recent Development
11.17 Upsher-Smith Laboratories
11.17.1 Upsher-Smith Laboratories Company Detail
11.17.2 Upsher-Smith Laboratories Business Overview
11.17.3 Upsher-Smith Laboratories Muscle Relaxers Introduction
11.17.4 Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2018-2023)
11.17.5 Upsher-Smith Laboratories Recent Development
11.18 Orient Pharma
11.18.1 Orient Pharma Company Detail
11.18.2 Orient Pharma Business Overview
11.18.3 Orient Pharma Muscle Relaxers Introduction
11.18.4 Orient Pharma Revenue in Muscle Relaxers Business (2018-2023)
11.18.5 Orient Pharma Recent Development
11.19 Daewoong Pharmaceutical
11.19.1 Daewoong Pharmaceutical Company Detail
11.19.2 Daewoong Pharmaceutical Business Overview
11.19.3 Daewoong Pharmaceutical Muscle Relaxers Introduction
11.19.4 Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023)
11.19.5 Daewoong Pharmaceutical Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Muscle Relaxers Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Methocarbamol
Table 3. Key Players of Cyclobenzaprine
Table 4. Key Players of Tizanidine
Table 5. Key Players of Baclofen
Table 6. Key Players of Others
Table 7. Global Muscle Relaxers Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Muscle Relaxers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Muscle Relaxers Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Muscle Relaxers Market Share by Region (2018-2023)
Table 11. Global Muscle Relaxers Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Muscle Relaxers Market Share by Region (2024-2029)
Table 13. Muscle Relaxers Market Trends
Table 14. Muscle Relaxers Market Drivers
Table 15. Muscle Relaxers Market Challenges
Table 16. Muscle Relaxers Market Restraints
Table 17. Global Muscle Relaxers Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Muscle Relaxers Market Share by Players (2018-2023)
Table 19. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2022)
Table 20. Ranking of Global Top Muscle Relaxers Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Muscle Relaxers Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Muscle Relaxers Product Solution and Service
Table 24. Date of Enter into Muscle Relaxers Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Muscle Relaxers Revenue Market Share by Type (2018-2023)
Table 28. Global Muscle Relaxers Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Muscle Relaxers Revenue Market Share by Type (2024-2029)
Table 30. Global Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Muscle Relaxers Revenue Market Share by Application (2018-2023)
Table 32. Global Muscle Relaxers Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Muscle Relaxers Revenue Market Share by Application (2024-2029)
Table 34. North America Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Muscle Relaxers Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Muscle Relaxers Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Muscle Relaxers Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Muscle Relaxers Product
Table 52. Pfizer Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Allergan Company Detail
Table 55. Allergan Business Overview
Table 56. Allergan Muscle Relaxers Product
Table 57. Allergan Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Ipsen Group Company Detail
Table 60. Ipsen Group Business Overview
Table 61. Ipsen Group Muscle Relaxers Product
Table 62. Ipsen Group Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 63. Ipsen Group Recent Development
Table 64. Teva Pharmaceuticals Company Detail
Table 65. Teva Pharmaceuticals Business Overview
Table 66. Teva Pharmaceuticals Muscle Relaxers Product
Table 67. Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 68. Teva Pharmaceuticals Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Muscle Relaxers Product
Table 72. Novartis Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Muscle Relaxers Product
Table 77. Johnson & Johnson Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Takeda Pharmaceutical Company Detail
Table 80. Takeda Pharmaceutical Business Overview
Table 81. Takeda Pharmaceutical Muscle Relaxers Product
Table 82. Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 83. Takeda Pharmaceutical Recent Development
Table 84. Sun Pharmaceutical Company Detail
Table 85. Sun Pharmaceutical Business Overview
Table 86. Sun Pharmaceutical Muscle Relaxers Product
Table 87. Sun Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 88. Sun Pharmaceutical Recent Development
Table 89. Merz Pharma Company Detail
Table 90. Merz Pharma Business Overview
Table 91. Merz Pharma Muscle Relaxers Product
Table 92. Merz Pharma Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 93. Merz Pharma Recent Development
Table 94. Mylan Company Detail
Table 95. Mylan Business Overview
Table 96. Mylan Muscle Relaxers Product
Table 97. Mylan Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 98. Mylan Recent Development
Table 99. Fresenius Kabi Company Detail
Table 100. Fresenius Kabi Business Overview
Table 101. Fresenius Kabi Muscle Relaxers Product
Table 102. Fresenius Kabi Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 103. Fresenius Kabi Recent Development
Table 104. Endo International Company Detail
Table 105. Endo International Business Overview
Table 106. Endo International Muscle Relaxers Product
Table 107. Endo International Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 108. Endo International Recent Development
Table 109. Par Sterile Products Company Detail
Table 110. Par Sterile Products Business Overview
Table 111. Par Sterile Products Muscle Relaxers Product
Table 112. Par Sterile Products Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 113. Par Sterile Products Recent Development
Table 114. Acorda Therapeutics Company Detail
Table 115. Acorda Therapeutics Business Overview
Table 116. Acorda Therapeutics Muscle Relaxers Product
Table 117. Acorda Therapeutics Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 118. Acorda Therapeutics Recent Development
Table 119. SteriMax Inc Company Detail
Table 120. SteriMax Inc Business Overview
Table 121. SteriMax Inc Muscle Relaxers Product
Table 122. SteriMax Inc Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 123. SteriMax Inc Recent Development
Table 124. Emcure Pharmaceuticals Company Detail
Table 125. Emcure Pharmaceuticals Business Overview
Table 126. Emcure Pharmaceuticals Muscle Relaxers Product
Table 127. Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 128. Emcure Pharmaceuticals Recent Development
Table 129. Upsher-Smith Laboratories Company Detail
Table 130. Upsher-Smith Laboratories Business Overview
Table 131. Upsher-Smith Laboratories Muscle Relaxers Product
Table 132. Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 133. Upsher-Smith Laboratories Recent Development
Table 134. Orient Pharma Company Detail
Table 135. Orient Pharma Business Overview
Table 136. Orient Pharma Muscle Relaxers Product
Table 137. Orient Pharma Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 138. Orient Pharma Recent Development
Table 139. Daewoong Pharmaceutical Company Detail
Table 140. Daewoong Pharmaceutical Business Overview
Table 141. Daewoong Pharmaceutical Muscle Relaxers Product
Table 142. Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 143. Daewoong Pharmaceutical Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Global Muscle Relaxers Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Methocarbamol
Table 3. Key Players of Cyclobenzaprine
Table 4. Key Players of Tizanidine
Table 5. Key Players of Baclofen
Table 6. Key Players of Others
Table 7. Global Muscle Relaxers Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Muscle Relaxers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Muscle Relaxers Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Muscle Relaxers Market Share by Region (2018-2023)
Table 11. Global Muscle Relaxers Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Muscle Relaxers Market Share by Region (2024-2029)
Table 13. Muscle Relaxers Market Trends
Table 14. Muscle Relaxers Market Drivers
Table 15. Muscle Relaxers Market Challenges
Table 16. Muscle Relaxers Market Restraints
Table 17. Global Muscle Relaxers Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Muscle Relaxers Market Share by Players (2018-2023)
Table 19. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2022)
Table 20. Ranking of Global Top Muscle Relaxers Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Muscle Relaxers Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Muscle Relaxers Product Solution and Service
Table 24. Date of Enter into Muscle Relaxers Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Muscle Relaxers Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Muscle Relaxers Revenue Market Share by Type (2018-2023)
Table 28. Global Muscle Relaxers Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Muscle Relaxers Revenue Market Share by Type (2024-2029)
Table 30. Global Muscle Relaxers Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Muscle Relaxers Revenue Market Share by Application (2018-2023)
Table 32. Global Muscle Relaxers Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Muscle Relaxers Revenue Market Share by Application (2024-2029)
Table 34. North America Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific Muscle Relaxers Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific Muscle Relaxers Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Muscle Relaxers Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa Muscle Relaxers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa Muscle Relaxers Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Muscle Relaxers Market Size by Country (2024-2029) & (US$ Million)
Table 49. Pfizer Company Detail
Table 50. Pfizer Business Overview
Table 51. Pfizer Muscle Relaxers Product
Table 52. Pfizer Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 53. Pfizer Recent Development
Table 54. Allergan Company Detail
Table 55. Allergan Business Overview
Table 56. Allergan Muscle Relaxers Product
Table 57. Allergan Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 58. Allergan Recent Development
Table 59. Ipsen Group Company Detail
Table 60. Ipsen Group Business Overview
Table 61. Ipsen Group Muscle Relaxers Product
Table 62. Ipsen Group Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 63. Ipsen Group Recent Development
Table 64. Teva Pharmaceuticals Company Detail
Table 65. Teva Pharmaceuticals Business Overview
Table 66. Teva Pharmaceuticals Muscle Relaxers Product
Table 67. Teva Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 68. Teva Pharmaceuticals Recent Development
Table 69. Novartis Company Detail
Table 70. Novartis Business Overview
Table 71. Novartis Muscle Relaxers Product
Table 72. Novartis Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Johnson & Johnson Company Detail
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Muscle Relaxers Product
Table 77. Johnson & Johnson Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Takeda Pharmaceutical Company Detail
Table 80. Takeda Pharmaceutical Business Overview
Table 81. Takeda Pharmaceutical Muscle Relaxers Product
Table 82. Takeda Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 83. Takeda Pharmaceutical Recent Development
Table 84. Sun Pharmaceutical Company Detail
Table 85. Sun Pharmaceutical Business Overview
Table 86. Sun Pharmaceutical Muscle Relaxers Product
Table 87. Sun Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 88. Sun Pharmaceutical Recent Development
Table 89. Merz Pharma Company Detail
Table 90. Merz Pharma Business Overview
Table 91. Merz Pharma Muscle Relaxers Product
Table 92. Merz Pharma Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 93. Merz Pharma Recent Development
Table 94. Mylan Company Detail
Table 95. Mylan Business Overview
Table 96. Mylan Muscle Relaxers Product
Table 97. Mylan Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 98. Mylan Recent Development
Table 99. Fresenius Kabi Company Detail
Table 100. Fresenius Kabi Business Overview
Table 101. Fresenius Kabi Muscle Relaxers Product
Table 102. Fresenius Kabi Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 103. Fresenius Kabi Recent Development
Table 104. Endo International Company Detail
Table 105. Endo International Business Overview
Table 106. Endo International Muscle Relaxers Product
Table 107. Endo International Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 108. Endo International Recent Development
Table 109. Par Sterile Products Company Detail
Table 110. Par Sterile Products Business Overview
Table 111. Par Sterile Products Muscle Relaxers Product
Table 112. Par Sterile Products Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 113. Par Sterile Products Recent Development
Table 114. Acorda Therapeutics Company Detail
Table 115. Acorda Therapeutics Business Overview
Table 116. Acorda Therapeutics Muscle Relaxers Product
Table 117. Acorda Therapeutics Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 118. Acorda Therapeutics Recent Development
Table 119. SteriMax Inc Company Detail
Table 120. SteriMax Inc Business Overview
Table 121. SteriMax Inc Muscle Relaxers Product
Table 122. SteriMax Inc Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 123. SteriMax Inc Recent Development
Table 124. Emcure Pharmaceuticals Company Detail
Table 125. Emcure Pharmaceuticals Business Overview
Table 126. Emcure Pharmaceuticals Muscle Relaxers Product
Table 127. Emcure Pharmaceuticals Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 128. Emcure Pharmaceuticals Recent Development
Table 129. Upsher-Smith Laboratories Company Detail
Table 130. Upsher-Smith Laboratories Business Overview
Table 131. Upsher-Smith Laboratories Muscle Relaxers Product
Table 132. Upsher-Smith Laboratories Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 133. Upsher-Smith Laboratories Recent Development
Table 134. Orient Pharma Company Detail
Table 135. Orient Pharma Business Overview
Table 136. Orient Pharma Muscle Relaxers Product
Table 137. Orient Pharma Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 138. Orient Pharma Recent Development
Table 139. Daewoong Pharmaceutical Company Detail
Table 140. Daewoong Pharmaceutical Business Overview
Table 141. Daewoong Pharmaceutical Muscle Relaxers Product
Table 142. Daewoong Pharmaceutical Revenue in Muscle Relaxers Business (2018-2023) & (US$ Million)
Table 143. Daewoong Pharmaceutical Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Muscle Relaxers Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Muscle Relaxers Market Share by Type: 2022 VS 2029
Figure 3. Methocarbamol Features
Figure 4. Cyclobenzaprine Features
Figure 5. Tizanidine Features
Figure 6. Baclofen Features
Figure 7. Others Features
Figure 8. Global Muscle Relaxers Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Muscle Relaxers Market Share by Application: 2022 VS 2029
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Muscle Relaxers Report Years Considered
Figure 14. Global Muscle Relaxers Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Muscle Relaxers Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Muscle Relaxers Market Share by Region: 2022 VS 2029
Figure 17. Global Muscle Relaxers Market Share by Players in 2022
Figure 18. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Muscle Relaxers Revenue in 2022
Figure 20. North America Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Muscle Relaxers Market Share by Country (2018-2029)
Figure 22. United States Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Muscle Relaxers Market Share by Country (2018-2029)
Figure 26. Germany Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Muscle Relaxers Market Share by Region (2018-2029)
Figure 34. China Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Muscle Relaxers Market Share by Country (2018-2029)
Figure 42. Mexico Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Muscle Relaxers Market Share by Country (2018-2029)
Figure 46. Turkey Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 49. Allergan Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 50. Ipsen Group Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 55. Sun Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 56. Merz Pharma Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 57. Mylan Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 58. Fresenius Kabi Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 59. Endo International Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 60. Par Sterile Products Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 61. Acorda Therapeutics Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 62. SteriMax Inc Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 63. Emcure Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 64. Upsher-Smith Laboratories Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 65. Orient Pharma Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 66. Daewoong Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Figure 1. Global Muscle Relaxers Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Muscle Relaxers Market Share by Type: 2022 VS 2029
Figure 3. Methocarbamol Features
Figure 4. Cyclobenzaprine Features
Figure 5. Tizanidine Features
Figure 6. Baclofen Features
Figure 7. Others Features
Figure 8. Global Muscle Relaxers Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 9. Global Muscle Relaxers Market Share by Application: 2022 VS 2029
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Muscle Relaxers Report Years Considered
Figure 14. Global Muscle Relaxers Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Muscle Relaxers Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Muscle Relaxers Market Share by Region: 2022 VS 2029
Figure 17. Global Muscle Relaxers Market Share by Players in 2022
Figure 18. Global Top Muscle Relaxers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Muscle Relaxers as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Muscle Relaxers Revenue in 2022
Figure 20. North America Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Muscle Relaxers Market Share by Country (2018-2029)
Figure 22. United States Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Muscle Relaxers Market Share by Country (2018-2029)
Figure 26. Germany Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Muscle Relaxers Market Share by Region (2018-2029)
Figure 34. China Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Muscle Relaxers Market Share by Country (2018-2029)
Figure 42. Mexico Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Muscle Relaxers Market Share by Country (2018-2029)
Figure 46. Turkey Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia Muscle Relaxers Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 49. Allergan Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 50. Ipsen Group Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 51. Teva Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 55. Sun Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 56. Merz Pharma Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 57. Mylan Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 58. Fresenius Kabi Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 59. Endo International Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 60. Par Sterile Products Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 61. Acorda Therapeutics Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 62. SteriMax Inc Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 63. Emcure Pharmaceuticals Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 64. Upsher-Smith Laboratories Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 65. Orient Pharma Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 66. Daewoong Pharmaceutical Revenue Growth Rate in Muscle Relaxers Business (2018-2023)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
